Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
Introduction: PRRT is an effective therapy for advanced NENs with SSTR-avid disease, however, the role of interval imaging in between PRRT cycles and its benefit is unknown.
Conference:
Presenting Author:
Authors: Grewal U, Patel R, Chandasekharan C,
Keywords: Peptide receptor radionuclide therapy, interval imaging, neuroendocrine tumour,
Introduction: PRRT has a major place in the therapeutic strategy of metastatic NETs. Its efficacy is generally evaluated after four cycles, with no early predictor identified to date. During each PRRT cycle, 177Lu-related gamma emissions can be measured by post-PRRT scintigraphy.
Conference:
Presenting Author:
Authors: Bando-Delaunay A, de Rycke O, Hentic O, Leclerc P, Allouch A,
Keywords: PRRT, scintigraphy, prediction, response,
Introduction: Tumor dosimetry protocols following Peptide Receptor Radionuclide Therapy (PRRT) have not yet been standardised and tumor absorbed dose does not hold clear value in predicting response to treatment.
Conference:
Presenting Author: Mileva M
Authors: Mileva M, Marin G, Levillain H, van Bogaert C, Critchi G,
Keywords: PRRT, tumor dose, 68Ga-DOTATATE, SUVmax, response,
Introduction: PRRT delivers targeted radionuclide therapy to Neuroendocrine Neoplasms (NENs) with high SSR expression.
Conference:
Presenting Author:
Authors: Alipour R, Jackson P, Callahan J, Bressel M, Hogg A,
#3458 Post-PRRT imaging: Which scans to make and what to look for
Introduction: Post-PRRT imaging often focuses on dosimetry but seldom on its clinical utility.
Conference:
Presenting Author: Aalbersberg E
Authors: Aalbersberg E, Huizing D, Tesselaar M, Stokkel M, Versleijen M,
Keywords: PRRT,